FDA rules in favor of Lannett in dispute over cocaine product
July 03, 2019 at 12:02 PM EDT
The federal agency's ruling means its review of Lannett's new drug application for a topical cocaine hydrocholride product can continue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|